Multiplex Screening for Pathogenic Hypertrophic Cardiomyopathy Mutations
This invention relates to a new method of screening for hypertrophic cardiomyopathy. In certain embodiments, the invention comprises a method of screening for hypertrophic cardiomyopathy comprising detecting the presence or absence of at least one pathogenic HCM mutation by mutation detection assay in a sample from a subject to be tested for hypertrophic cardiomyopathy.
DERMODY JAMES J [US]; SCHWALB MARVIN [US]; TOLIAS PETER [US]
Type of Offer:
« More Biotech Patents